Childhood Cancer

You are here

Home » Grants » All grants tagged with "General Pediatric Cancer"

All grants tagged with "General Pediatric Cancer"

Modeling GATA2 Associated MDS/AML Predisposition Syndrome Using Color-Barcoding and Mutagenesis in Zebrafish
Serine Avagyan, PhD
Dana-Farber Cancer Institute
Young Investigator Grants, Awarded 2018
Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients
Rachael Schulte, MD
Vanderbilt University Medical Center
Young Investigator Grants, Awarded 2018
Augmenting Chimeric Antigen Receptor T Cell Induced Epitope Spreading for Pediatric Solid Tumors
Michael Leibowitz, MD/PhD
Children’s Hospital of Philadelphia
Young Investigator Grants, Awarded 2018
Describing the Biological Impacts of Gain-of-function SAMD9 Mutations
Jason Schwartz, MD/PhD
Vanderbilt University Medical Center
Young Investigator Grants, Awarded 2018
Pedi-PRESTO: Pediatric Patient-Reported Symptom Tracking in Oncology
Allison Barz Leahy, MD
Children’s Hospital of Philadelphia
Young Investigator Grants, Awarded 2018
Characterize the Effect of Risk Variant in SMAD6 (Rs12438941, G>A) On Langerhans Cell Histiocytosis Disease Pathogenesis
Meryl V. Hahne
Tulane University
POST Program Grants, Awarded 2018
Implementation Research for Improving Medical Information Management in Global HOPE Uganda
Vamsi Chintagumpala Mohan
Boston College
POST Program Grants, Awarded 2018
CSF Digital Droplet PCR Analysis for Pediatric High-Grade Glioma Diagnosis and Therapy Response
Kyle Wierzbicki
University of Michigan
POST Program Grants, Awarded 2018
Immunity in Alveolar Soft Part Sarcomagenesis
Sydney Lambert
Vassar College
POST Program Grants, Awarded 2018
PDL-1 Expression on Tumor Cells Mediates C8 Cytotoxic T Cell (CTL) Resistance
Taylor Pearl
Ohio State University
POST Program Grants, Awarded 2018

Pages

All childhood cancer types

Featured Hero

Sam Glossi

At 3-and-a-half years old, Sam's parents found a large lump on Sam's abdomen. He underwent surgery to remove it and was cancer-free for a short time. When the cancer returned, it was treated like stage 4 neuroblastoma. Sam has been cancer-free since 2017!
Read more »